CONTINENTAL STRATEGY, LLC

Lobbying for IMMIX BIOPHARMA, INC. · A clinical-stage biopharmaceutical company.

Filing Registration

1st Quarter (Jan 1 - Mar 31) 2026 · California · posted Feb 19, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Issues related to the FDA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem